A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer.
Saved in:
| Title: | A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer. |
|---|---|
| Authors: | Mukhtar RA; University of California San Francisco, San Francisco, USA. Rita.Mukhtar@ucsf.edu., Gottipati S; University of California San Francisco, San Francisco, USA., Yau C; University of California San Francisco, San Francisco, USA., López-Tarruella S; Instituto de Investigación Sanitaria Gregorio Marañón Madrid, Madrid, Spain., Earl H; University of Cambridge, Cambridge, UK., Hayward L; Western General Hospital, Edinburgh, UK., Hiller L; University of Warwick, Coventry, UK., Osdoit M; Institut Curie, Paris, France., van der Noordaa M; Université de Rouen, Rouen, France., de Croze D; Institut Curie, Paris, France., Hamy AS; Institut Curie, Paris, France., Laé M; Institut Curie, Paris, France.; Université de Rouen, Rouen, France., Reyal F; Institut Curie, Paris, France., Sonke GS; Netherlands Cancer Institute, Amsterdam, The Netherlands., Steenbruggen TG; Netherlands Cancer Institute, Amsterdam, The Netherlands., van Seijen M; Netherlands Cancer Institute, Amsterdam, The Netherlands., Wesseling J; Netherlands Cancer Institute, Amsterdam, The Netherlands., Martín M; Instituto de Investigación Sanitaria Gregorio Marañón Madrid, Madrid, Spain., Del Monte-Millán M; Instituto de Investigación Sanitaria Gregorio Marañón Madrid, Madrid, Spain., Boughey JC; Mayo Clinic, Rochester, USA., Goetz MP; Mayo Clinic, Rochester, USA., Hoskin T; Mayo Clinic, Rochester, USA., Valero V; University of Texas MD Anderson Cancer Center, Houston, USA., Edge SB; Roswell Park Cancer Institute, Buffalo, USA., Abraham JE; University of Cambridge, Cambridge, UK., Bartlett JMS; Ontario Institute for Cancer Research, Toronto, Canada.; Edinburgh Cancer Research Centre, Edinburgh, UK.; University of Toronto, Toronto, Canada., Caldas C; University of Cambridge, Cambridge, UK., Dunn J; University of Warwick, Coventry, UK., Provenzano E; University of Cambridge, Cambridge, UK., Sammut SJ; University of Cambridge, Cambridge, UK., Thomas JS; Western General Hospital, Edinburgh, UK., Graham A; Western General Hospital, Edinburgh, UK., Hall P; Western General Hospital, Edinburgh, UK., Mackintosh L; Western General Hospital, Edinburgh, UK., Fan F; University of Kansas Medical Center, Kansas City, USA., Godwin AK; University of Kansas Medical Center, Kansas City, USA., Schwensen K; University of Kansas Medical Center, Kansas City, USA., Sharma P; University of Kansas Medical Center, Kansas City, USA., DeMichele AM; University of Pennsylvania, Philadelphia, USA., Cole K; Yale University, New Haven, USA., Pusztai L; Yale University, New Haven, USA., Kim MO; University of California San Francisco, San Francisco, USA., J van 't Veer L; University of California San Francisco, San Francisco, USA., Cameron D; Western General Hospital, Edinburgh, UK., Esserman LJ; University of California San Francisco, San Francisco, USA., Fraser Symmans W; University of Texas MD Anderson Cancer Center, Houston, USA. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2025 Feb 13; Vol. 11 (1), pp. 14. Date of Electronic Publication: 2025 Feb 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4677 |
|---|---|
| DOI: | 10.1038/s41523-025-00720-3 |
